Rohner, Eduarde
Witman, Nevin
Sohlmer, Jesper
De Genst, Erwin
Louch, William E.
Sahara, Makoto
Chien, Kenneth R. http://orcid.org/0000-0002-2759-8378
Funding for this research was provided by:
European Research Council (AdG743225)
Karolinska Institutet/AstraZeneca Integrated Cardio Metabolic Centre
Vetenskapsrådet (Dnr 541-2013-8351)
Karolinska Institute
Article History
Received: 28 March 2021
Accepted: 24 August 2021
First Online: 8 September 2021
Declarations
:
: According to the national ethical legislation, embryonic stem cell lines can be used as any other human cell line if the embryonic stem cells cannot be in any way traced back to the original donor. Therefore, no special ethical permits are needed to be able to perform research using this human embryonic stem cell line.
: Not applicable.
: N.W, W.L, M.S, declare no conflict of interest. E.G is employed by AstraZeneca, E.R and J.S hold stocks in Moderna Therapeutics and K.C. is a scientific founder and equity holder in Moderna Therapeutics, and chair of the External Science Panel for AstraZeneca.